Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells
Keywords: PLK1, polo-like kinase 1; siRNA, small-interfering RNA; CTR, control; PC3, PC3 prostate cancer cells; HMEC-1, human microvascular endothelial cells; eGFP, enhanced Green Fluorescent Protein; IC50, half maximal death concentration; DRI, dose reduction inde